Failed efficacy of fluoxetine in the treatment of posttraumatic stress disorder: Results of a fixed-dose, placebo-controlled study

Journal of Clinical Psychopharmacology

Volumn 27, Issue 2, 2007, Pages 166-170

  Martenyi, Ferenc ^a,b   Brown, Eileen B ^b   Caldwell, Catherine D ^b  

^a Lilly Research Laboratories   (Austria)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; PLACEBO;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; AUTOMUTILATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GASTRITIS; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; POSTTRAUMATIC STRESS DISORDER; PRIORITY JOURNAL; RATING SCALE; RHINITIS; SCORING SYSTEM; SOMNOLENCE; SUICIDAL IDEATION; THORAX PAIN; TREATMENT RESPONSE;

ADULT; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISORDERS OF EXCESSIVE SOMNOLENCE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; FLUOXETINE; HEADACHE; HUMANS; MALE; MIDDLE AGED; NAUSEA; PATIENT DROPOUTS; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; STRESS DISORDERS, POST-TRAUMATIC; TIME FACTORS; TREATMENT FAILURE; WITHHOLDING TREATMENT;

EID: 34247152611     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/JCP.0b013e31803308ce     Document Type: Article

References (22)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Washington, DC: American Psychiatric Association; 1994.
2. Brady K, Pearlstein T, Asnis GM, et al. Efficacy and safety of sertraline treatment of posttraumatic stress disorder. A randomized controlled trial. JAMA. 2000;283:1837-1844.
3. Davidson JRT, Rothbaum BO, van der Kolk BE, et al. Multicenter, double blind comparison of sertraline and placebo in the treatment of posttraumatic stress disorder. Arch Gen Psychiatry. 2001;58:485-492.
4. Marshall RD, Beebe KL, Oldham M, et al. Efficacy and safety of paroxetine treatment of chronic PTSD: a fixed-dose, placebo-controlled study. Am J Psychiatry. 2001;158:1982-1988.
5. Tucker P, Zaninelli R, Yehuda R, et al. Paroxetine in the treatment of chronic posttraumatic stress disorder. Results of a placebo-controlled, flexible-dose titration trial. J Clin Psychiatry. 2001;62:860-868.
6. Connor KM, Sutherland SM, Tupler LA, et al. Fluoxetine in posttraumatic stress disorder: randomised, double-blind study. Br J Psychiatry. 1999;175:17-22.
7. Davinson J, Rothbaum BO, Tucker P, et al. Venlafaxine extended release in posttraumatic stress disorder: a sertraline- and placebo-controlled study. J Clin Psychopharmacol. 2006;26(3):259-267.
8. Davidson JRT, Kudler H, Saunders WB, et al. Treatment of posttraumatic stress disorder with amitriptyline and placebo. Arch Gen Psychiatry. 1990;47(3):259-266.
9. Kosten TR, Frank JB, Dan E, et al. Pharmacotherapy for post-traumatic stress disorder using phenelzine or imipramine. J Nerv Ment Dis. 1991;179(6):366-370.
10. Katz RJ, Lott MH, Arbus P, et al. Pharmacotherapy of post-traumatic stress disorder with a novel psychotropic. Anxiety. 1994;1(4):169-174.
11. Baker DG, Diamond BI, Gillette G, et al. A double-blind, randomized, placebo-controlled, multi-center study of brofaromine in the treatment of post-traumatic stress disorder. Psychopharmacology (Berl). 1995;122(4):386-389.
12. Herzberg MA, Feldman ME, Beckham JC, et al. Lack of efficacy for fluoxetine in PTSD: a placebo-controlled trial in combat veterans. Ann Clin Psychiatry. 2000;59:460-464.
13. Gottlieb S. Sertraline approved for post-traumatic stress disorder. BMJ. 1999;319:1089.
14. Martenyi F, Brown E, Zhang H, et al. Fluoxetine versus placebo in posttraumatic stress disorder. J Clin Psychiatry. 2002;63(3):199-206.
15. First MB, Spitzer RL, Gibbon M, et al. Structured Clinical Interview for DSM-IV Axis I Disorders (SCID-I). Washington, DC: American Psychiatric Press; 1997.
16. Blake DD, Weathers FW, Nagy LM, et al. The development of a clinician administered PTSD scale. J Trauma Stress. 1995;8:75-90.
17. Guy W. ECDEU Assessment Manual for Psychopharmacology, Revised. Rockville, MD: National Institute of Mental Health, Psychopharmacology Research Branch; 1976:217-222, 313-331.
18. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382-389.
19. Davidson JR, Colket JT. The eight-item treatment-outcome post-traumatic stress disorder scale: a brief measure to assess treatment outcome in post-traumatic stress disorder. Int Clin Psychopharmacol. 1997;12(1):41-45.
20. Davidson JR, Book SW, Colket JT, et al. Assessment of a new self-rating scale for post-traumatic stress disorder. Psychol Med. 1997;27(1):153-160.
21. Hamilton M. The assessment of anxiety states by rating. Br J Psychiatry. 1959;32:50-55.
22. Bernstein EM, Putnam FW. Development, reliability, and validity of a dissociation scale. J Nerv Ment Dis. 1986;174(12):727-735.